+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Brain metastases in patients with limited small cell lung cancer achieving complete remission. Correlation with TNM staging

Brain metastases in patients with limited small cell lung cancer achieving complete remission. Correlation with TNM staging

Chest 96(6): 1332-1335

We reviewed the brain metastases, after treatment, of 45 patients with limited small cell lung cancer who achieved complete remission by radiochemotherapy or curative operation. No patient received prophylactic cranial irradiation. The incidence of subsequent brain metastases was classified according to pretreatment staging as follows: two of 13 (15 percent) patients in stage I; two of ten (20 percent) in stage II; nine of 17 (53 percent) in stage IIIa; and four of five (80 percent) in stage IIIb. The brain metastases occurred from seven to 29 months after the start of treatment, and the median time of the occurrence was 13 months. Of 17 patients who developed brain metastases and who subsequently received cranial irradiation, there were two in whom relapse had occurred at no other site except the brain and who survived 26 and 79 months after the relapse, respectively. These data indicate that not all patients with limited SCLC achieving CR due to treatment necessarily benefit from PCI.

(PDF emailed within 1 workday: $29.90)

Accession: 007069144

Download citation: RISBibTeXText

PMID: 2555114

Related references

Brain Metastases in Patients with Limited Small Cell Lung Cancer Achieving Complete Remission. Chest Journal 96(6): 1332-1335, 1989

Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience. Journal of Thoracic Oncology 3(6): 652-655, 2008

Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission. Cochrane Database of Systematic Reviews: Cd002805-Cd002805, 2000

Complete Remission of Brain Metastases in Non-Small Cell Lung Cancer Patients Harboring an EGFR Mutation Treated with Tyrosine Kinase Inhibitor without Radiotherapy: A Report of 3 Cases. Case Reports in Oncology 7(1): 149-154, 2014

Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy. Strahlentherapie und Onkologie 187(12): 826-830, 2012

Screening of brain metastasis with limited magnetic resonance imaging (MRI): clinical implications of using limited brain MRI during initial staging for non-small cell lung cancer patients. Journal of Korean Medical Science 20(1): 121-126, 2005

Survival of patients with limited small cell lung cancer in whom complete remission was obtained (a non-randomised retrospective study of 124 consecutive patients. Lung Cancer 13(2): 129-135, 1995

Do all patients with non small cell lung cancer and brain metastases have a limited survival. Proceedings of the American Association for Cancer Research & American Society of Clinical Oncology 22: 507, 1981

Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?. Journal of Thoracic Oncology 1(3): 205-210, 2007

P14.17 What is the optimal therapeutic strategy for limited brain metastases (Bms) from non small cell lung cancer (Nsclc)? Prognostic factors conditioning brain control and patients outcome. Neuro-Oncology 19(suppl_3): iii105-iii106, 2017

Complete remissions in afatinib-treated non-small-cell lung cancer patients with symptomatic brain metastases. Anti-Cancer Drugs 27(9): 914-915, 2017

Limited value of CT brain scans in the staging of small cell lung cancer. Ajr. American Journal of Roentgenology 140(1): 37-40, 1983

Complete metabolic remission with Gefitinib in a hemodialysis patient with bone metastases from non-small cell lung cancer. Anticancer Research 34(1): 319-322, 2014

Prophylactic cranial irradiation in limited disease small-cell lung cancer in complete remission: a retrospective analysis. Respiratory Medicine 95(3): 235-236, 2001

Long-term results of prophylactic cranial irradiation for limited-stage small-cell lung cancer in complete remission. Chinese Medical Journal 118(15): 1258-1262, 2005